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Abstract
Objectives: Urinary Tract Infections (UTIs) are one of the most common infections diagnosed in the United
Kingdom (UK). The prevalence of Extended-Spectrum-Β-Lactamase (ESBL) producing UTIs has dramatically risen,
limiting treatment options. The emergence and spread of ESBLs is thought to be through the horizontal transmission
of antibiotic resistance plasmids IncL/M, IncF, IncN and IncI1. These conjugative plasmids have been described as
important vectors and directly linked to major outbreaks of antibiotic resistance. This study aimed to investigate the
prevalence of ESBLs in Leicestershire, UK and their relationship with antibiotic resistance plasmids.
Methods: 236 ESBL producing uropathogenic Enterobacteriaceae isolates were obtained from the Leicester
Royal Infirmary (Leicestershire, UK). ESBL production was confirmed phenotypically via the MAST ID double disc
synergy test. ESBL-producing genes (CTX-M, SHV, TEM and OXA) were identified by multiplex PCR. The CTX-M
family was then further characterised into (CTX-M-1, CTX-M-2, CTX-M-8, CTX-M-9 and CTX-M-25) by multiplex
PCR. The relationship between ESBL-producing genes and plasmid type was then investigated by multiplex PCR-
based replicon typing to detect IncFIA, IncI1, IncL/M, IncN and IncFII.
Results: ESBL genes were identified as follows: CTX-M (71.6%), OXA (7.6%), TEM (3.8%) and SHV (3.8%).
Multiple resistance genes were detected in 16% of isolates. CTX-M genes were identified as follows: CTX-M-1
(84.1%), CTX-M-9 (12.5%), CTX-M-25 (1.7%), CTX-M-8 (1.1%) and CTX-M-2 (0.6%). Replicon typing results were
as follows: IncL/M (29.2%), IncN (14.4%), IncI1 (5.1%), IncFII (27.5%) and IncFIA (23.3%). A combination of IncL/M,
IncFII and IncFIA was the most common at 9.8%. A positive correlation between CTX-M and all plasmids except
IncI1 was found.
Conclusion: CTX-M harbouring Enterobacteriaceae are associated with multiple plasmids, which can be linked
to its rapid spread across the world. Prevalence studies help to inform policy about antibiotic stewardship and
resistance evolution, aiming to reduce resistance levels in the future.
Keywords: Extended-spectrum-β-lactamases; Multiplex PCR;
Antibiotic resistance; CTX-M; Urinary tract infection; Replicon typing;
One health approach
Introduction
Urinary Tract Infections (UTIs) are one of the most common
bacterial infectious diseases diagnosed in outpatients in the UK. Of the
causes of UTIs, Uropathogenic Escherichia coli (UPEC) are the most
prevalent [1]. Risk factors for acquiring a UTI include previous
exposure to 3rd and 4th generation cephalosporins and
fluroquinolones, hospitalisation, old age, female gender, recurrent UTI
infection, diabetes and catheterisation [1].
The most common type of resistance in UTIs is β-lactamase
production, resulting in extended-spectrum β-lactamase (ESBL)
producing bacteria [2]. These bacteria produce enzymes that can
hydrolyse oxyimino-cephalosporins (ceftriaxone, cefotaxime,
ceftazidime and cefepime) and monobactams (aztreonam) but not
cephamycins and carbapenems. Based on their amino acid sequence,
these enzymes have been classed into four groups-A-D [2]. Class A
enzymes have been shown to be the most clinically important, due to
their link to treatment failure, increased morbidity, mortality and
healthcare costs. In contrast to the class A, C and D serine β-
lactamases, class B are metallo-β-lactamases. Class C β-lactamases are
AmpCs, conferring resistance to not only third-generation
cephalosporins but also β-lactam/β-lactamase inhibitor combinations.
The most important class D β-lactamase is the OXA-type. There are 3
main families of class A: TEM, SHV and CTX-M while TEM, SHV and
OXA ESBLs arise via substitutions in strategically positioned amino
acids from the natural narrow-spectrum TEM-1/-2, SHV-1 and
OXA-10 β-lactamases, all CTX-M variants demonstrate an ESBL
phenotype [2]. Previously, most ESBLs detected were of the TEM/SHV
group. From the 1990’s the CTX-M family became increasingly more
common, and now it is reported to be the most prevalent type of ESBL
detected at present worldwide [2]. The worldwide dissemination and
dramatically increasing prevalence of the CTX-M family of ESBLs is
due to the selective pressure caused by the over-use, and more
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Risk factors for an ESBL-producing UTI are; recent hospitalisation,
treatment with 3rd generation Cephalosporins, old age (over 65),
diabetes, recurrent UTI, indwelling catheters and female gender [3]. It
has been reported that ESBL-producing isolates are more likely to be
associated with significant pyuria, suggesting that ESBLs are more
likely to cause a clinically significant UTI [4,5]. Although most ESBL-
producing UTIs are acquired in the community, a hospitalised patient
is approximately 4 times more likely to be diagnosed with an ESBL-
producing UTI [3].
The significant increase in movement of livestock and agricultural
produce and human travel has facilitated the rapid amalgamation and
dissemination of antibiotic resistance genes [6]. The emergence and
spread of antibiotic resistance determinants is often through horizontal
transmission of mobile genetic elements such as plasmids. [7]
It is the large, low-copy, self-transmitting resistance conjugative
plasmids that are increasingly threatening the efficacy of antibiotics for
Gram-negative infections and have been directly linked to antibiotic
resistance outbreaks. Conjugative plasmids can carry more than one
gene for a selectable advantage such as antibiotic resistance genes and
virulence factors such as bacteriocins and cytotoxins. Under antibiotic
and infectious pressure, these traits may facilitate the successful spread
of certain plasmid types between different bacterial hosts and
geographical locations [8]. This results in ESBL-producing isolates that
can show resistance to other types of antibiotics, leading to multidrug
resistance (MDR). MDR limits treatment options, resulting in less
favourable outcomes for patients [9]. Surveillance of the spread of
these plasmids can help track antibiotic resistance determinants and
phylogenetic and comparative analysis can identify the origin and
evolution of these genes [10].
Many papers have discussed the importance of plasmids in the
spread of blaCTX-M genes, especially CTX-M-1 [11-16]. Studies have
suggested that CTX-M is primarily associated with plasmids of IncF,
IncL/M, IncN and IncI1 and these have been termed as “epidemic
resistance plasmids” in Enterobacteriaceae [11,15,17,18]. It is suggested
that these plasmids are successful as they likely provide virulence and
antimicrobial resistance determinants, such as ESBL-production, that
contributes to the fitness of the bacterial host. They also guarantee
their survival and stability in the host through the production of
several addiction systems, such as toxin-antitoxin systems. Therefore,
they are maintained without the need for selective pressure of
antibiotic treatment. This could explain the rapid dissemination of
CTX-M genes within Enterobacteriaceae [19-21].
Realising the major health concern that antibiotic resistance
presents, the world health organisation (WHO) developed a global
strategy for the containment of antimicrobial resistance in 2001. This
involved monitoring the prevalence of ESBLs in the UK, and other
countries all over the world. Prevalence studies help to inform policy
on infection prevention and antibiotic stewardship. They allow
monitoring of evolution of antibiotic resistance genes and prediction of
possible future evolution [22]. The importance of surveillance was
reiterated in the O’Neill report where it was suggested that all
antibiotic prescriptions should be informed by up-to-date surveillance
information [23-25].
Prevalence studies are an important way of monitoring the
transmission of resistance determinants between vectors, and whether
stewardship and other measures are working effectively [23]. The aim
of this study is to identify the prevalence of the different ESBL types in
Leicestershire by multiplex PCR. PCR-based replicon typing will be
used to investigate whether prevalence is associated with antibiotic
resistance plasmids. We hypothesise that the prevalence of ESBLs in
this area is related to the conjugative resistance plasmids IncL/M, IncF,
IncN and IncI1.
Materials and Methods
Isolate collection and phenotypic detection
Bacterial isolates (n=236) of Enterobacteriaceae isolated from
urinary tract infections were obtained from the Leicester Royal
Infirmary hospital (Leicester, England). The Leicester Royal Infirmary
was chosen as a collection site as a large number of samples are
received from all over the Midlands and the Midlands has a large
population of a wide variety of ethnic groups. According to the 2011
Census, 20.8% of people in the West Midlands and 14.6% of people in
the East Midlands identify as an ethnicity other than white British [26].
Specifically in the city of Leicester, 49.5% of people identify as non-
white British, of this 37.1% identify as Asian/Asian British [27]. ESBL
production was confirmed phenotypically via the MAST ESBL ID
double disc synergy method, conforming to British Society of
Antimicrobial Chemotherapy (BSAC) standards [28]. Discs contained
Cefotaxime, Ceftazidime and Cefpodoxime with an ESBL inhibitor
(Clavulanic acid) counterpart. Plates were incubated for 18 hours at
37°C. A zone of inhibition difference of 5 mm or more between the β-
lactam and the ESBL inhibitor clavulanic acid indicated a positive
result for ESBL production. Four control isolates were obtained from
Public Health England: NCTC 13353 (CTX-M-15), NCTC 13351
(TEM-3), NCTC 13368 (SHV-18) and NCTC 13442 (OXA-48) for use
as controls in phenotypic and genotypic tests.
Ethical approval
Ethical approval for this study was not required as Informed consent
from patients was not required, as we collected only waste material
(bacterial cultures), and therefore there is no link to patient data.
DNA extraction and genotypic detection by multiplex PCR
We have previously outlined the method used for DNA extraction
[29]. Genotypic identification was by means of a multiplex PCR
method for the detection of the ESBL-producing genes (CTX-M, SHV,
TEM and OXA). These were then further characterised into the CTX-
M family (CTX-M-1, CTX-M-2, CTX-M-8, CTX-M-9 and CTX-
M-25) by adapting a multiplex PCR assay by Al-Mahayie [30]. The
GoTaq G2 Flexi DNA Polymerase kit was chosen for all PCR assays
(Promega,Southampton, UK). PCR amplification reactions were
performed using the PikoReal® 96 well RT-PCR platform
(ThermoFisher, Loughborough, UK) in a volume of 25 μl containing 5
μl buffer, 2 μl MgCl2, 0.5 μl DNTPs, 0.125 μl Taq polymerase, 400 nM
of each primer, 2.5 μl of DNA template and made up to 25 μl with
water.
Cycling parameters for the first multiplex assay were as follows: an
initial denaturation at 94°C for 5 min, followed by 35 cycles of 94°C for
30 s, annealing at 65°C for 1 min (gradual temperature decrements of
0.5°C per cycle, final annealing temperature 48°C), and 72°C for 1 min;
and with a final extension at 72°C for 10 min.
Cycling parameter for the second multiplex assay were as follows:
initial denaturation at 94°C for 5 min; 30 cycles of 94°C for 25 s; 52°C
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for 40s and 72°C for 50 s; and a final extension at 72°C for 6 min.
Primers can be found in Table 1.
Primer Forward Primer Reverse Primer References
TEM-1 CGG ATG GCA TGA CAG TAA GAG AGG ACC ACT TCT GCG CTC G [29]
SHV-18 CTCAAGGATGTATTGTGGTTATGC CTA CGA GCC GGA TAA CGC G [29]
CTX-M CGTCATCTATGTTCGCCGAC GCATCTCAGTCGGATCGAGC [29]
OXA-48 CGGAATGCCTGCGGTAGCAAAG CAGCCCTAAACCATCCGATG [29]
CTX-M-1 AAA AAT CAC TGC GCC AGT TC AGC TTA TTC ATC GCC ACG TT [30]
CTX-M-2 AGC TTA TTC ATC GCC ACG TT CCA GCG TCA GAT TTT TCA GG [30]
CTX-M-8 TCG CGT TAA GCG GAT GAT GC CAA AGA GAG TGC AAC GGA TG [30]
CTX-M-9 CAA AGA GAG TGC AAC GGA TG ATT GGA AAG CGT TCA TCA CC [30]
CTX-M-25 GCA CGA TGA CAT TCG GG AAC CCA CGA TGT GGG TAG C [30]
Table 1: Primers used in this study. Primers for the first multiplex PCR assay were TEM, SHV, CTX-M and OXA. The primers for the second
multiplex PCR assay were CTX-M-1, CTX-M-2, CTX-M-8, CTX-M-9 and CTX-M-25. Primers were designed using the OligoAnalyzer 3.1
(Integrated DNA Technologies Inc, Illinois, USA) Primers were then checked for specificity by the BLAST software (National Center for
Biotechnology Information, Bethesda, USA).All PCR products were ran on a 2% agarose gel (UltraPure™ Agarose, ThermoFisher Scientific,
Paisley, UK) for 90 mins at 60 Volts. A GeneRuler 50 bp DNA Ladder, ready-to-use (ThermoFisher Scientific, Paisley, UK) was used for
comparison.
Multiplex PCR-based replicon typing
Each isolate was sub-cultured in Luria Βni broth overnight at 37°C.
Plasmids were extracted using the Illustra PlasmidPrep Mini Spin Kit
(GE Healthcare Life Sciences, Buckinghamshire, UK) Detection of
plasmids was by means of adapting the replicon typing assay designed
by [31]. PCR amplifications were performed in a volume of 25ul
containing 5 µl buffer, 2 µl magnesium chloride, 0.5 µl DNTPs, 0.125 µl
Taq polymerase, 400 nM of each primer and 2.5 µl of plasmid DNA.
Cycling parameters were as follows: initial denaturation at 94°C for 5
min 30 cycles of denaturation at 94°C for 1 min, annealing at 65°C for
30 sec, extension at 72°C for 30 sec and a final extension at 72°C for 5
min. Primers can be found below in Table 2.
Statistical analysis
The Chi Square test was used for statistical comparison and the
Spearman Rank Correlation test was used to analyse the relationship
between plasmids and ESBLs. P values < 0.05 were regarded as
significant.
Primer Forward Primer Reverse Primer Reference
IncFII TGTTTCCACTATGACCCGCT TGATACATCGAGGGCAGCAA This study
IncI1 CGGGAATGTCTGTTGTTGCA ATCGGCTTCATCCTGGTGAA This study
IncFIA CCA TGC TGG TTC TAG AGAAGGTG GTATATCCTTACTGGCTTCCGCAG [31]
IncN GTCTAACGAGCTTACCGAAG GTTTCAACTCTGCCAAGTTC [31]
IncL/M GGATGAAAACTATCAGCATCTGAAG CTGCAGGGGCGATTCTTTAGG [31]
Table 2: Primers used in multiplex replicon-typing. Primers for IncFII, IncI1, IncFIA, IncN and IncL/M were designed using the OligoAnalyzer
3.1 (Integrated DNA Technologies Inc, Illinois, USA) Primers were then checked for specificity by the BLAST software (National Center for
Biotechnology Information, Bethesda, USA). All PCR products were ran on a 2% agarose gel (UltraPure™ Agarose, ThermoFisher Scientific,
Paisley, UK) for 90 mins at 60 Volts. A GeneRuler 50 bp DNA Ladder, ready-to-use (ThermoFisher Scientific, Paisley, UK) was used for
comparison.
Results
236 Enterobacteriaceae were tested by multiplex PCR for the ESBL
genes CTX-M, TEM, SHV and OXA; and the CTX-M sub-groups
CTX-M-1, CTX-M-2, CTX-M-8, CTX-M-9 and CTX-M-25. Multiplex
PCR-based replicon typing tested for IncFII, IncFIA, IncL/M, IncN
and IncI1.
The PCR assay assigned the four controls to their correct
phylogenetic groups. ESBL genes were identified as follows: CTX-
M=169 (71.6%) OXA=18 (7.6%), TEM=9 (3.8%) and SHV=9 (3.8%).
Multiple resistance genes were detected in 16% of isolates, specifically
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CTX-M+OXA=16 (6.8%), CTX-M+TEM=12 (5.1%), CTX-M+OXA
+SHV=5 (2.1%) and CTX-M+SHV=5 (2.1%). This can be seen in
Table 1. 31 isolates did not contain any of the four genes tested.
CTX-M genes were identified as follows: CTX-M-1=148 (84.1%),
CTX-M-9=22 (12.5%), CTX-M-25=3 (1.7%), CTX-M-8=2 (1.1%) and
CTX-M-2=1 (0.6%). This can be seen in Table 2. All isolates identified
as containing CTX-M in the previous assay, contained at least one of
the CTX-M sub-groups tested. One isolate contained both CTX-M-1
and CTX-M-8.





CTX-M + OXA 16
CTX-M + OXA + SHV 5
CTX-M + SHV 5
CTX-M + TEM 12
Table 3: Frequency of ESBL producing UTI isolates in the
Leicestershire area. 236 isolates were tested for the presence of CTX-M,
TEM, OXA and SHV genes by multiplex PCR analysis. All genes were

























Figure 1: Frequency of replicon types in ESBL producing UTI
isolates in the Leicestershire area. 236 isolates were tested for the
presence of IncL/M, IncN, IncI1, IncFII and IncFIA genes by
multiplex replicon-typing PCR analysis. All genes were detected,
however IncL/M was the most frequent, followed closely by IncFII.
Plasmids identified were as follows: IncL/M was detected in 69
(29.2%) of isolates, IncFII was detected in 65 (27.5%) of isolates, IncN
was detected in 34 (14.4%) of isolates, IncFIA was detected in 55
(23.3%) of isolates and IncI1 was detected in 12 (5.1%) of isolates. This
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Figure 2: Frequency of dual, triple and quadruple plasmids in ESBL
producing UTI isolates in the Leicestershire area. 236 isolates were
tested for the presence of IncL/M, IncN, IncI1, IncFII and IncFIA
genes by multiplex PCR analysis. All genes were detected, however
CTX-M was the most frequent.
Multiple plasmids were found in 37% of isolates. . IncL/M, IncFII
+IncFIA was detected in 23 (9.8%) isolates. IncN+IncFII was detected
in 13 (5.5%) isolates. IncL/M+IncN was detected in 12 (5.1%) isolates.
IncFII+IncFIA was detected in 12 (5.1%) isolates. IncL/M+IncFIA was
detected in 11 (4.7%) isolates. IncL/M, IncI1+IncFIA was detected in 3
(1.3%) isolates IncL/M, IncN and IncFII was detected in 3 (1.3%)
isolates. IncI1 and IncFII was detected in 3 (1.3%) isolates. IncN, IncI1,
IncFII+IncFIA was detected in 2 (0.9%) isolates. IncL/M+IncFII was
detected in 2 (0.9%) isolates (Figure 2). IncL/M+IncI1 was detected in
1 (0.4%) isolate. IncN, IncI1+IncFII was detected in 1 (0.4%) isolate.
IncI1+IncFIA was detected in 1 (0.4%) isolate. This can be found in
Table 4.






CTX-M-1 + CTX-M-8 1
Table 4: Frequency of CTX-M sub-groups in UTI isolates in the
Leicestershire area. 169 isolates previously identified as containing the
CTX-M gene, were tested for the presence of CTX-M-1, CTX-M-2,
CTX-M-8, CTX-M-9 and CTX-M-25 genes by multiplex PCR analysis.
All genes were detected, however CTX-M-1 was the most frequent. A
combination of CTX-M-1 and CTX-M-8 was found.
A spearman rank was carried out to access the correlation between
ESBL genes and plasmid type. Results can be found in Table 5. A
significant positive correlation between the CTX-M gene and IncL/M,
N, FII and FIA plasmids was found. Also found was a significant
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positive correlation between the IncFII plasmid and the CTX-M-8
gene. None of the other CTX-M sub-types (CTX-M-1, CTX-M-2,
CTX-M-9 and CTX-M-25) had a significant correlation with any of
the plasmids. No significant correlation was found for the TEM, SHV
and OXA genes and any of the plasmids.



























































































Table 5: Correlation coefficients and associated level of significance for the establishing the association between the plasmids and the ESBL genes
CTX-M, TEM, OXA, SHV, CTX-M-1, CTX-M-2, CTX-M-8, CTX-M-9 and CTX-M-25. Correlation was determined using Spearman Rank
analysis. A value 1=perfect correlation; 0-1=no correlation; 0--1=one variable increases as the other decreases; -1-0= perfect inverse correlation. P
values are given in brackets and P values <0.05 were regarded as significant.
Discussion
The major cause of antibiotic resistance in Enterobacteriaceae is
ESBL-production. ESBL-producing UTIs are a major problem in the
UK, due to their increasing prevalence and limited treatment options
[32]. Given how common ESBL-producing infections are worldwide,
prevalence studies are important to ascertain where resistance is a
major problem.
In this paper, the prevalence of ESBL genes was investigated in UTIs
in the Leicestershire area of the UK. In short, the CTX-M gene was
found in 71.6% of samples, in comparison genes TEM, SHV and OXA
were detected in ≤ 16% of samples. The most prevalent CTX-M was
CTX-M-1 at 84.1%. The most common plasmid found was IncL/M at
29.2%, with IncFII following closely at 27.5%. Multiple plasmids were
found in 37% of isolates, with the IncL/M, IncFII and IncFIA
combination the most common. A significant correlation between
CTX-M and all plasmids except IncI1and more specifically, CTX-M-8
and IncFII was found, however no other gene family significantly
correlated with any of the plasmids.
Here, the relevance of our findings to other studies will be evaluated
within the context of the One Health Approach. The One Health
Approach describes a holistic and multisectoral approach to
antimicrobial resistance, as resistant organisms exist in humans,
animals, food and the environment [33]. The main aim of the One
Health Approach is to ensure that antimicrobial agents continue to be
effective by developing policies that promote the responsible use of
antimicrobial agents. The development of policy decisions depend on
economic and scientific evidence. Prevalence studies are an important
part of this [34].
As far as we are aware, this is the first study to investigate the
prevalence of ESBL-producing Enterobacteriaceae and their
relationship to plasmids, in the Leicestershire area of the UK.
In this study, we found that CTX-M was the most common ESBL
and the most common sub-group was CTX-M-1. This is comparable
with other European countries, and is consistent with the worldwide
dissemination of the CTX-M ESBL [9,15,35,36]. CTX-M-1 has been
found to be the most prevalent gene in humans, animals and food in
the UK, frequently found in poultry and cattle isolates [37]. It has been
established that the prevalence of ESBLs differs significantly between
countries. Within Europe, a high prevalence has been seen in Southern
Europe, while a generally lower prevalence is seen in Northern Europe.
Outside of Europe, Turkey and India have reported high levels of
ESBLs [13].
The high number of CTX-M isolates found in this area may be due
to the multicultural nature of the Leicestershire community. A study in
a hospital in Birmingham, UK also found a high level of ESBL and
suggested that this could be due to a high immigrant population [5].
One possible cause of elevated levels of ESBLs in high immigrant
populations could be faecal colonisation. Transmission of faeces to the
urinary tract is frequently a cause of UTI. As E.coli is a common
inhabitant of the gastrointestinal tract, it is possible that CTX-M-
harbouring E.coli could be a commensal bacterium that can become
pathogenic upon colonization of the urinary tract [38]. To further this,
a direct link between conjugative resistance plasmids in the micro flora
and increased treatment failure has been found [39]. In another study
in Birmingham, they found a direct link between place of birth and
CTX-M-1 colonisation in stool samples. Those that were originally
born in Afghanistan saw the highest colonisation at 60%, followed by
those born on the Indian subcontinent (India, Pakistan, Bangladesh or
Sri Lanka) with a 25% colonisation. Those that travel to certain areas
were also associated with CTX-M colonisation. Travellers to South
Asia (India, Pakistan, Bangladesh, Sri Lanka or Nepal) in the last year
had a 38.5% colonisation, suggesting a geographical, rather than ethnic
susceptibility [36].
In India, a prevalence rate of 53% for CTX-M was seen in a study
detecting ESBLs in UTIs. Antibiotic usage in India is far higher than in
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the UK, due to issues with lack of restriction in antibiotic prescribing
which could explain why they saw a higher incidence of CTX-M [40].
Prevalence rates of CTX-M have been seen as high as 94.4% in Iran,
73% in Mexico, 98.7% in Japan and 100% in Ghana [36]. These studies
show that the problem of ESBL producing infections is not limited to
the UK. As bacteria do not recognise geographical borders, so too does
our approach to tackling AMR need to be borderless.
We found that 16% of isolates contained more than one ESBL type.
Interestingly, in all of the multi-ESBL isolates CTX-M was always
present, this suggests that CTX-M may play a key role in the
production of MDR bacteria. Of these, CTX-M and OXA were the
most common multi-ESBL, detected in 16 isolates. 2% of isolates
contained three genes, specifically, CTX-M, OXA and TEM. It has
been reported that CTX-M-15 combined with an OXA-30 gene can
survive β-lactamase inhibitors, since OXA-30 is poorly inhibited and
also confers resistance to cefepime [12]. Although we did not
specifically type the ESBL genes in these isolates, it is possible that it
could be this combination present. The coexistence of CTX-M and
other antibiotic resistance genes could be one of the reasons why CTX-
M has been so successful. This has been found elsewhere, with
incidences of combinations of ESBLs as high as 95.4%, with regards to
the CTX-M and SHV combination [41,42]. Our combination of three
genes has also been found elsewhere [42]. Furthermore, other Multi
ESBL combinations have also been found in animals and the
environment, suggesting that multiple ESBL combinations are not
limited to humans. This data combined shows that multi ESBLs are
widespread and could pose a significant threat [4,43].
A similar incidence of ESBLs has been reported in livestock and
companion animals globally [44-47]. In a study looking at canine
UPEC in Switzerland, CTX-M-1 was found in 28.6% of ESBL-
producers suggesting that dogs, a common companion animal
worldwide, may be a reservoir for CTX-M-1 spread into humans [47].
With raw meat a speciality in some countries and the rise of raw food
diets in both humans and companion animals, a high level of ESBLs in
livestock is a cause for concern. Both livestock and companion animals
could be considered a major vector of ESBL-producing bacteria [37].
As it has been suggested that the majority of ESBL infections are
community-acquired, this could suggest a relationship between
companion animals, livestock and humans.
This study focused on the prevalence of IncL/M, IncFII, IncI1,
IncFIA and IncN. These conjugative plasmids have previously been
associated with the dissemination of antibiotic resistance determinants
such as ESBLs, in Enterobacteriaceae and other bacteria.
Whilst IncL/M was the most common plasmid found in the isolates
tested, when IncFII and IncFIA (both members of the IncF group) are
combined, the frequency is far higher at 50.8%. The IncF group is one
of the most common plasmids found in UTI isolates and is frequently
associated with CTX-M [12]. Studies show that IncL/M is also highly
common, and both have been termed as “epidemic” plasmids [11].
Both of these plasmids can persist for months without the need for
selective pressure by antibiotic usage [39]. This suggests that simply
reducing antibiotics by antibiotic stewardship alone will not reduce the
prevalence of these plasmids.
The distribution of plasmids harbouring ESBL genes in this
population differs from the distribution described in other studies.
Studies have agreed that CTX-M is associated with IncN, IncFII and
IncL/M, however reports have shown that CTX-M is also associated
with IncI1. IncI1 plasmids harbouring CTX-M have been described in
the UK, US, Belgium, Netherlands, France and Australia in isolates
from horse, cattle and human isolates [16]. Studies have also found
that other ESBL types are associated with particular plasmids. It has
been found that SHV can be associated with IncFII, IncL/M and IncI1.
Likewise, TEM can be associated with the same plasmids, and
additionally IncI1 [19]. A reason for the differing results could be due
to different antibiotic and environmental selection pressures in this
population, leading to selection of CTX-M harbouring IncL/M, IncF,
and IncN plasmids, but not IncI1 plasmids.
In this study, no significant correlation between CTX-M-1 (the most
common CTX-M subtype) and any other plasmid was found. There are
conflicting reports within the literature with regards to the most
significant association between CTX-M-1 and plasmid types. Some
reports suggest a correlation between CTX-M-1 and IncFII, whilst
others, mainly in Europe, suggest a correlation between CTX-M-1 and
IncI1. Other reports suggest no overall correlation at all [37,48]. It
appears that the association between CTX-M-1 and plasmids differs
between geographical locations and sample type. These differences in
reports could be attributed to socioeconomic factors, animals and
number of samples. It could be suggested that CTX-M-1 is equally
adapted to most plasmid types therefore a significant correlation
between just one plasmid was not seen. It could also be suggested that
the high level of CTX-M-1 in this population is also due to another
mechanism other than conjugative plasmids, such as chromosomally
mediated resistance.
A significant correlation between CTX-M-8 and IncFII was found.
Whilst CTX-M-8 is not the highest prevailing gene found in this study,
it is a significant finding, as IncFII was very common. A link has been
found between CTX-M-8 harbouring IncI1 plasmids and companion
animals. This could further strengthen the argument that CTX-M
genes could be passed, via plasmids, from companion animals to
humans [46].
Though studies suggest that IncN does not contribute to the
prevalence of CTX-M in humans to the same extent as incI1, this was
not the case in this study, as IncN was seen to be more prevalent than
IncI1 and a significant correlation was found [21]. This theory has also
been contradicted by another study that found that IncN was in fact
associated with humans and 95.5% of isolates containing IncN
harboured CTX-M-1 [37]. In a Danish study, IncN plasmids carrying
CTX-M-1 were seen in both pigs and farm workers, and it was
demonstrated that these plasmids were transmitted within the farm,
showing animal to human transmission of these plasmids harbouring
CTX-M [11].
Multi-replicon plasmids were found in 37% of isolates. Multiple
plasmids frequently occur in the same bacterial cell, however, cross-
interference between plasmid replicons guarantees that the most
closely related plasmids are incompatible and cannot stably persist
together [39]. When multi-replicon plasmids occur, generally one
replicon is usually highly conserved, and the other is free to diverge.
This gives the bacterial host the benefit of being able to change
antibiotic resistance determinants and virulence factors, depending on
antibiotic pressure and environment [16]. Multi-replicons have been
found in other UTI isolates, and multi-replicons containing multiple
IncF types appear to be common [12]. Multi replicons are also
common in the environment. A study found that the diversity of
plasmids found in the environment was higher than in UTIs in the
same area. CTX-M-1’s in the environment have been shown to be
associated with IncI1 and IncN [43]. A report has suggested a direct
link between wastewater treatment plants and ESBL-producing UTIs.
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Sewage sludge used for agriculture may be one of the ways that ESBL-
producing isolates enter the food chain [43]. It has been established
that CTX-M-1 harbouring E.coli in manure spread on fields can
survive in the soil for at least a year. This demonstrates the capability of
antibiotic resistant bacteria to survive under environmental conditions
in the absence of antibiotic selection pressure [21].
A limitation of this study is that isolates were not categorised into
source of isolate (community/hospital acquired). However, other
studies suggest that the CTX-M family and ESBLs in general are
associated with community-acquired infection [4,49]. In this study, we
only collected ESBL-positive isolates. From this, we cannot determine
the level of ESBL resistance as a whole. This study should be followed
up regularly, to study the trends of antibiotic resistance in this area.
More surveillance studies on animal and environmental isolates are
needed, to fully understand the relationship between these and human
infections.
We have reported similar results to what has been found in the rest
of the UK and worldwide. CTX-M-harbouring Enterobacteriaceae is a
major threat to patient care and healthcare costs. Genotypic prevalence
studies are an important contribution to the understanding and
prediction of antibiotic resistance evolution and antibiotic stewardship.
Knowledge of plasmid types circulating in bacterial populations is vital
to advancing a new prospective to control these plasmids, such as
replicon-targeting compounds. A strategy to prevent the further
dissemination of these plasmids needs to be implemented.
Combined, these findings highlight the importance of restricting
antibiotics sales to only those with medical prescriptions and
appropriate use, as many low and middle-income countries have not
yet enforced policies that prevent widespread self-medication with
antibiotics.
This study reinforces the One Health approach and underpins the
importance of antibiotic stewardship and infection prevention schemes
in humans, animals, food production and the environment in order to
limit the spread of ESBL-harbouring Enterobacteriaceae, not only in
the UK, but worldwide.
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